Reshma Kewalramani became President & CEO of Vertex in 2020. She joined the company in 2017 as Senior Vice President and went on to serve as Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs. Before Vertex, Ms. Kewalramani held senior leadership positions at Amgen, including as Vice President, Head of U.S. Medical Organization and Vice President, Head Nephrology and Metabolic Therapeutic Area, Global Clinical Development.
